98 results
10-Q
2024 Q1
IMCR
Immunocore Holdings plc
8 May 24
Quarterly report
7:00am
the bifurcation of embedded derivatives depends on the nature of the host contract and the features of the derivatives. In accounting for the issuance … trials of our product candidates due to the inherently unpredictable nature of preclinical and clinical development. Clinical and preclinical development
DEF 14A
IMCR
Immunocore Holdings plc
12 Apr 24
Definitive proxy
4:20pm
nature or conditions. Transactions involving compensation for services provided to us as an employee or director are not covered by this policy … and state that a member has the right to ask questions at the meeting in accordance with the Act.
49.2
The notice shall specify the general nature
424B7
IMCR
Immunocore Holdings plc
5 Apr 24
Prospectus with selling stockholder info
4:34pm
or arrangement with us shall declare the nature of his interest at a meeting of the directors.
A director shall not vote in respect of any transactions … and his ruling in relation to any director other than himself shall be final and conclusive except in a case where the nature or extent of the interest
PRE 14A
IMCR
Immunocore Holdings plc
2 Apr 24
Preliminary proxy
4:45pm
nature or conditions. Transactions involving compensation for services provided to us as an employee or director are not covered by this policy. A related … at the meeting in accordance with the Act.
49.2
The notice shall specify the general nature of the business to be transacted at the meeting and shall
S-3ASR
IMCR
Immunocore Holdings plc
20 Mar 24
Automatic shelf registration
8:51pm
or arrangement with us shall declare the nature of his interest at a meeting of the directors.
A director shall not vote in respect of any transactions … and his ruling in relation to any director other than himself shall be final and conclusive except in a case where the nature or extent
10-K
97aybvfte3emvph
28 Feb 24
Annual report
7:33am
10-K
EX-10.13
2dw0jl5n
28 Feb 24
Annual report
7:33am
10-K
EX-10.14
5rd0i
28 Feb 24
Annual report
7:33am
10-K
EX-10.12
kjy4cq vw9zvfd2ej
28 Feb 24
Annual report
7:33am
8-K
EX-4.1
j27ft1lmam7qfdrh1
2 Feb 24
Immunocore Prices Upsized Convertible Senior Notes Offering
4:05pm
6-K
EX-99.1
ele v3ee2
7 Nov 23
Current report (foreign)
7:09am
6-K
EX-99.2
wgiztwybay
7 Nov 23
Current report (foreign)
7:09am
6-K
EX-99.1
rvojau7
10 Aug 23
Current report (foreign)
8:28am
6-K
EX-99.2
pgeolrp2anh4bvi
10 Aug 23
Current report (foreign)
8:28am
6-K
EX-99.1
8jbu8ty
10 May 23
Current report (foreign)
7:27am
6-K
EX-99.2
6bh4 kl66a
10 May 23
Current report (foreign)
7:27am
6-K/A
EX-99.1
aodeowo2kh
18 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
4:17pm
6-K
EX-99.2
etf2ca5wf
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.1
56jtoubjc7anxgzvpv
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.4
16e9n5qxot 15z9abm7
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am